In the war against drug-resistant diseases and so-called “superbugs”, the family of bacteria known as CREs are a particularly nasty bunch. But two UConn scientists may be gaining new ground against the public health threat. Professors Amy Anderson and Dennis Wright, along with their students in the School of Pharmacy, have developed a group of drug compounds that appear to be particularly effective against CREs in early tests.